⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Morvarid RezaieD.O.

Internal Medicine · Fort Worth, TX 76104

NPI: 1164692026

Share:

36

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peersHigh long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)

Risk indicators are statistical patterns, not allegations. Learn more

10,235

Total Claims

$1.5M

Drug Cost

634

Beneficiaries

$2,424

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Long-acting opioid rate+8
Elderly antipsychotic prescribing+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+734%

Opioid rate vs peers

18.7% vs 2.2% avg

+72%

Cost per patient vs peers

$2,424 vs $1,411 avg

+23%

Brand preference vs peers

13.0% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 734% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

18.7%

Opioid Rate

1,910

Opioid Claims

$193K

Opioid Cost

26.5%

Long-Acting Rate

Brand vs Generic

87% generic

Brand: 1,324 claims · $1.2M

Generic: 8,827 claims · $264K

Patient Profile

70

Avg Age

66%

Female

2.32

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About